Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Total Current Liabilities (2016 - 2022)

Historic Total Current Liabilities for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $41.5 million.

  • Avadel Pharmaceuticals' Total Current Liabilities rose 13603.23% to $41.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $41.5 million, marking a year-over-year increase of 13603.23%. This contributed to the annual value of $21.0 million for FY2021, which is 3899.0% up from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Total Current Liabilities stood at $41.5 million, which was up 13603.23% from $46.2 million recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Total Current Liabilities ranged from a high of $87.2 million in Q1 2018 and a low of $9.1 million during Q1 2021
  • For the 5-year period, Avadel Pharmaceuticals' Total Current Liabilities averaged around $34.2 million, with its median value being $32.3 million (2020).
  • In the last 5 years, Avadel Pharmaceuticals' Total Current Liabilities plummeted by 7179.61% in 2021 and then skyrocketed by 38270.83% in 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Total Current Liabilities (Quarter) stood at $38.4 million in 2018, then dropped by 6.25% to $36.0 million in 2019, then plummeted by 58.01% to $15.1 million in 2020, then surged by 38.99% to $21.0 million in 2021, then soared by 97.67% to $41.5 million in 2022.
  • Its last three reported values are $41.5 million in Q3 2022, $46.2 million for Q2 2022, and $44.0 million during Q1 2022.